Long-Term Complications and Treatments: Dyslipidemia Steve V. Edelman, MD Robert R. Henry, MD Dyslipidemia Lipid abnormalities that accelerate atherosclerosis and increase the risk of CV disease are significantly more common in patients with type 2 diabetes than in nondiabetic individuals. In addition, central obesity associated with type 2 diabetes is …

Long-Term Complications: Macrovascular Steve V. Edelman, MD Robert R. Henry, MD The long-term, chronic complications of diabetes have the greatest impact on the health of individuals with diabetes as well as on the health care system. Diabetes and its associated vascular complications are the fourth leading cause of death in …

Metabolic: Hyperosmolar Hyperglycemic Nonketotic Syndrome Steve V. Edelman, MD Robert R. Henry, MD This acute metabolic complication is a life-threatening crisis with a high mortality rate that usually is seen in: Elderly patients with Type 2 diabetes (particularly those in nursing homes without access to free water) People with undiagnosed …

Treatment Algorithm Steve V. Edelman, MD Robert R. Henry, MD The primary treatment goals of managing Type 2 diabetes are to: • Eliminate symptoms of hyperglycemia • Recognize the symptoms of hypoglycemia….

Assessment of the Treatment Regimen Steve V. Edelman, MD Robert R. Henry, MD   Certain key clinical and metabolic parameters should be monitored during office visits:

Assessment of the Treatment Regimen, Part 2 Steve V. Edelman, MD Robert R. Henry, MD Measuring Other Glycated Proteins Enhanced glycation of other proteins occurs in diabetes and has been proposed as another method of assessing average glucose control. Because of….  

Selecting an Insulin Preparation, Chapter 9 – Part 2 Steve V. Edelman, MD, Professor of Medicine, Division of Endocrinology and Metabolism, University of California, San Diego Robert R. Henry, MD, Professor of Medicine, Division of Endocrinology and Metabolism, University of California, San Diego There are three types of insulin: animal, …

Assessment of the Treatment Regimen, Part 3 Steve V. Edelman, MD Robert R. Henry, MD Self-Monitoring of Blood Glucose (SMBG) Systems A combination of factors affect the overall performance of SMBG systems…

Application of Intensive Insulin Therapy, Chapter 9 – Part 3 Steve V. Edelman, MD, Professor of Medicine, Division of Endocrinology and Metabolism, University of California, San Diego Robert R. Henry, MD, Professor of Medicine, Division of Endocrinology and Metabolism, University of California, San Diego     The goals of therapy …

Assessment of the Treatment Regimen, Part 4 Steve V. Edelman, MD Robert R. Henry, MD Applying SMBG Results to Adjust Insulin Doses Patients can be taught how to analyze and use SMBG data to effectively make adjustments in their insulin doses so that they can maintain and improve glycemic control…. …